NDC 59630-300-20 - Nitrolingual
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59630-300
- Requested NDC
- 59630-300-20
- Package NDCs from labels
- 59630-300-65, 59630-300-20
- Manufacturer
- FIRST HORIZON PHARMACEUTICAL CORPORATION
- Effective date
- 2006-06-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nitrolingual - FIRST HORIZON PHARMACEUTICAL CORPORATION | FIRST HORIZON PHARMACEUTICAL CORPORATION | 2006-06-02 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59630-300-20 | GM - Gram | 59630-300 | adebc8b2-0e71-4fd5-b2ba-2d26ca9aca2c | 1 | 2016-02-04 |
| 59630-300-65 | GM - Gram | 59630-300 | 5084d8ba-6562-42d7-be58-d3779ebfc725 | 1 | 2016-02-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| nitroglycerin | ACTIVE INGREDIENT | G59M7S0WS3 | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 | |
| nitroglycerin | ACTIVE MOIETY | G59M7S0WS3 | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 | |
| dehydrated alcohol | INACTIVE INGREDIENT | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 | ||
| medium-chain partial glycerides | INACTIVE INGREDIENT | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 | ||
| medium-chain triglycerides | INACTIVE INGREDIENT | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 | ||
| peppermint oil | INACTIVE INGREDIENT | NITROLINGUAL (NITROGLYCERIN) SPRAY [FIRST HORIZON PHARMACEUTICAL CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NITROGLYCERIN LINGUAL | NITROGLYCERIN | Allegis Pharmaceuticals, LLC | fadd07b7-189b-4678-ad0f-bf1e4d3d1300 | 2025-12-17 | Warnings, Adverse reactions | 705129 |
| NITROGLYCERIN | NITROGLYCERIN | HF Acquisition Co LLC, DBA HealthFirst | 422b4713-9531-f1bf-e063-6294a90ada2b | 2025-10-27 | Warnings, Adverse reactions | 705129 |
| NITROGLYCERIN LINGUAL | NITROGLYCERIN LINGUAL | HF Acquisition Co LLC, DBA HealthFirst | 947e4e68-ef8a-6c63-e053-2a95a90ac193 | 2025-01-08 | Warnings, Adverse reactions | 705129 |
| NITROGLYCERIN LINGUAL | NITROGLYCERIN LINGUAL | HF Acquisition Co LLC, DBA HealthFirst | 9483ea48-0b1e-68c0-e053-2995a90a84d5 | 2025-01-08 | Warnings, Adverse reactions | 705129 |
| NITROLINGUAL | NITROGLYCERIN | INDEPENDENCE PHARMACEUTICALS, LLC | d19b5f51-ca85-48d6-9ccd-8ae26249cdc3 | 2024-05-13 | Warnings, Adverse reactions | 995019 705129 |
| NITROGLYCERIN LINGUAL | NITROGLYCERIN LINGUAL | HF Acquisition Co LLC, DBA HealthFirst | a8eb91f6-7f2e-7d57-e053-2995a90a3893 | 2024-02-22 | Warnings, Adverse reactions | 705129 |
| Nitroglycerin | NITROGLYCERIN | Prasco Laboratories | f9731c86-34b0-42a2-8b39-eca907e02e74 | 2024-01-01 | Warnings, Adverse reactions | 705129 |
| nitroglycerin lingual | NITROGLYCERIN | Padagis Israel Pharmaceuticals Ltd | e7bbeff1-e4f1-43a6-a1b3-a8c3dcae817d | 2022-09-01 | Warnings, Adverse reactions | 705129 |
| 1D350400-D80E-24EE-19DA-F13D9EB4ED8D | de06a4da-ea70-441e-bba2-e40eb51a8c3a | 2006-06-02 | Warnings, Adverse reactions | 1D350400-D80E-24EE-19DA-F13D9EB4ED8D de06a4da-ea70-441e-bba2-e40eb51a8c3a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.